Your browser doesn't support javascript.
loading
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance.
Lai, Xin; Gupta, Shailendra K; Schmitz, Ulf; Marquardt, Stephan; Knoll, Susanne; Spitschak, Alf; Wolkenhauer, Olaf; Pützer, Brigitte M; Vera, Julio.
Afiliação
  • Lai X; Laboratory of Systems Tumour Immunology, Department of Dermatology, Friedrich-Alexander-University of Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Gupta SK; Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany.
  • Schmitz U; CSIR-Indian Institute of Toxicology Research, Lucknow, India.
  • Marquardt S; Gene & Stem Cell Therapy Program, Centenary Institute, University of Sydney, Camperdown, Australia.
  • Knoll S; Sydney Medical School, University of Sydney, Camperdown, Australia.
  • Spitschak A; Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Centre, Rostock, Germany.
  • Wolkenhauer O; Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Centre, Rostock, Germany.
  • Pützer BM; Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Centre, Rostock, Germany.
  • Vera J; Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany.
Theranostics ; 8(4): 1106-1120, 2018.
Article em En | MEDLINE | ID: mdl-29464002
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Regulação para Baixo / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Regulação para Baixo / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article